Aker BioMarine ASA - Base prospectus approved for listing of bonds

The Financial Supervisory Authority of Norway has on 16 June 2025 approved thebase prospectus with appendices prepared by Aker BioMarine ASA in connectionwith the listing of the company's most recent bond issue on the Oslo StockExchange: ISIN NO0013326025 - FRN Senior Secured Bond Issue 2024/2027

The prospectus with appendices and Final Terms is available on the company'swebsite: https://www.akerbiomarine.com/investor

Lysaker, 16 June 2025Aker BioMarine ASA

For further information, please contact Christopher Robin Vinter, VP IR & Corporate FinanceMobile: +47 911 60 820 Email: Christopher.vinter@akerbiomarine.com

This information is subject to the disclosure requirements pursuant to MARArticle 19 and Section 5-12 of the Norwegian Securities Trading Act.

About Aker BioMarine: Aker BioMarine is a leading human health and nutrition innovator that developskrill-derived products for consumer health and nutrition. Krill is a natural,powerful, and health-promoting source of nutrients from the pristine waters ofAntarctica, and Aker BioMarine has a unique position in its industry. Theingredient portfolio consists of Superba Krill Oil, Lysoveta, Revervia, andPL+,as well as the consumer brand, Kori Krill. The innovative approach alsoextendsinto the spin-offs AION (reduce and recycle plastic waste across industries)andUnderstory (a protein brand). Aker BioMarine is listed on the Oslo StockExchange (AKBM). More information is available at www.akerbiomarine.com.

https://newsweb.oslobors.no/message/649302